Yestar Healthcare Holdings Company Limited

[Yestar Healthcare 2393.HK] Exporting Masks Overseas, Planning to Increase Capacity and Introduce Medical N95 Production Lines

Yestar Healthcare further releases disposable medical masks to support domestic and global combats of the Coronavirus outbreak

[Yestar Healthcare 2393.HK] Developed disinfection consumable products to support the combat of the Coronavirus Outbreak

[Yestar 2393.HK] Fujifilm Becomes A Strategic Partner of Yestar Healthcare By Investing Not Less than HK$411.7 Million

[Yestar Healthcare 2393.HK] Yestar Healthcare Announces 2017 Annual Results: Revenue Increased by 30.0% and Profit for the Year Surged by 29.9% yoy (16 Mar 2018)

[Yestar2393.HK]Grand Opening of ‘Shanghai Zhongke Runda Precision Medical Laboratory’, which is Collaboratively Launched by Yestar, Chinese Academy of Sciences and Runda Medical

[Yestar Healthcare 2393.HK] Announces 2016 Annual Results; Gross profit margin Increased by 48.1% to RMB766 Million; Profit for the Year Surged by 36.0% yoy to RMB270 Million

[Yestar International 2393.HK] Announces 2016 Interim Results Revenue Increased by 43.7% to 1.44 Billion Profit for the Period Surged by 109.1% yoy to 140.1 Million

[Yestar 2393.HK] 2015 Interim Results Positive Profit Alert, Consolidated Net Profit Is Expected to Record Not Less Than 55% Growth

[Yestar 2393.HK] Allotment and issuance of 320 million Subscription Shares raises HK$960 million for the acquisition of medical consumable distribution network in Shanghai Introduces healthcare specific investors as strategic shareholders